|
Market Closed -
NSE India S.E.
07:05:07 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 1,463.00 INR | 0.00% |
|
+0.21% | -3.20% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12.39B | |||||
| 48.85B | |||||
| 41.43B | |||||
| 12.46B | |||||
| 9.08B | |||||
| 7.53B |
- Stock Market
- Stocks
- CIPLA Stock
- Charts Cipla Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
